Page 32 - product-manual
P. 32

TM/MC  TM/MC
                                                                                                  REFERENCES






            Abidov M, Crendal F, Grachev S, et al. (2003). Effect of extracts from Rhodiola rosea and Rhodiola crenulata (Crassulaceae) roots on ATP content in mitochondria of skeletal
            muscles. Bulletin of Experimental Biology and Medicine. 136(6): 585-7.

            Alternative Medicine Review. (AMR) (2004). “Withania somnifera”. FindArticles.com. 28 Nov, 2011.

            Asano K, Takahashi T, Miyashita M, et al. (1986). Effect of Eleutheroccocus senticosus extract on human physical working capacity. Planta Medica. 52(3): 175-7.

            Balch P. (2006). Prescription for Nutritional Healing, 4th Edition: A Practical A-to-Z Reference to Drug-Free Remedies Using Vitamins, Minerals, Herbs & Food. Avery Penguin
            Putnam. New York (USA).

            Bensky D, Gamble A. (1993). Chinese Herbal Medicine Materia Medica (Revised Ed), Eastland Press, Seattle (WA). 317-318.

            Brinker F. (2001). Herb Contraindications and Drug Interactions, 3rd ed. Sandy (OR): Eclectic Medical Publications.

            Chang H, But P. (1987) Pharmacology and Applications of Chinese Materia Medica, Vol 2. Singapore. World Scientific. 1041-1046.

            Chen JK, Chen TT. (2004). Chinese Medical Herbology and Pharmacology. California, Art of Medicine Press.

            De Bock K, Eijnde BO, Ramaekers M, Hespel P. (2004). Acute Rhodiola rosea intake can improve endurance exercise performance. International Journal of Sport Nutrition and
            Exercise Metabolism. 14(3): 298-307.

            Evdokimov VG. (2009). Effect of cryopowder Rhodiola rosae L. on cardiorespiratory parameters and physical performance of humans (in Russian). Aviakosmicheskaia i
            Ekologicheskaia Meditsina. 43(6): 52-6.

            Gold LS, Sloan TH. (1999). “Ranking Possible Toxic Hazards of Dietary Supplements Compared to Other Natural and Synthetic Substances.”  Testimony to F.D.A., Docket No.
            99N-1174.

            Hellum BH, Tosse A, Hoybakk K, et al. (2010) Potent in vitro inhibition of CYP3A4 and P-glycoprotein by Rhodiola rosea. Planta Medica. 76(4):331-8.

            Huang L, Zhao H, Huang B, et al. (2011). Acanthopanax senticosus: review of botany, chemistry and pharmacology. Pharmazie. 66(2): 83-97.

            Kurkin VA, Zapesochnaya GG. (1985). Chemical composition and pharmacological characteristics of Rhodiola rosea [review]. Journal of Medicinal Plants, Russian Academy of
            Science (Moscow). 1231-445.

            McRae S. (1996). Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng. CMAJ. 155(3):293-5.

            Mills S, Bone K. (2000). “Astragalus”. Principles and Practice of Phytotherapy. Edinburgh (Scotland): Churchill Livingstone. 273-279.

            Mills S, Bone K. (2000). “Siberian Ginseng” Principles and Practice of Phytotherapy. Edinburgh (Scotland), Churchill Livingstone. 534-541.

            Parisi A, Tranchita E, Duranti G, et al. (2010). Effects of chronic Rhodiola Rosea supplementation on sport performance and antioxidant capacity in trained male: preliminary
            results. Journal of Sports Medicine and Physical Fitness. 50(1): 57-63.

            Puotinen CJ. (1997). The Encyclopedia of Natural Pet Care. Keats Publishing, Illinois (USA).

            Schwartz S. Psychoactive Herbs in Veterinary Behavior Medicine. Blackwell Publishing, 2005. Iowa, USA.

            Singh B, Saxena AK, Chandan BK, et al. (2001). Adaptogenic activity of a novel, withanolide-free aqueous fraction from the roots of Withania somnifera Dun. Phytotherapy
            Research. 15(4): 311-318.








                                                                                                    Adapt-VM TM       |  7
   27   28   29   30   31   32   33   34   35   36   37